Axiom Investors LLC Aclaris Therapeutics, Inc. Transaction History

Axiom Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$16.46 - $20.33 $783,166 - $967,301	-47,580 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$17.08 - $25.64 $81,386 - $122,174	-4,765 Reduced 9.1%	47,580 $834,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $409,840 - $530,674	-19,089 Reduced 26.72%	52,345 $1.29 Million
Q3 2017 Nov 09, 2017	BUY	$23.02 - $28.8 $30,524 - $38,188	1,326 Added 1.89%	71,434 $1.84 Million
Q2 2017 Aug 14, 2017	BUY	N/A	70,108	70,108 $1.9 Million

100

52.2M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $78M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.